Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline demographic characteristics and comorbid conditions.

From: Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study

Characteristic Study sample
Age (years)  
   N 73
   Mean (SD) 78.3 (7.0)
   Median (range) 79 (58 -- 92)
Gender, n (%)  
   Female 45 (61.6)
   Male 27 (37.0)
   Missing 1 (1.4)
Ethnicity, n (%)  
   White, non-Hispanic 26 (35.6)
   Missing 47 (64.4)
Reported comorbid disease, n (%) 63 (86.3)
Comorbid disease, n (%)  
   Diabetes 5 (6.8)
   Cancer 13 (17.8)
   Asthma 4 (5.5)
   Chronic obstructive pulmonary disease 2 (2.7)
   Arthritis and rheumatism 22 (30.1)
   Headache (migraine, cluster) 1 (1.4)
   Chronic neck or back pain 1 (1.4)
   Heart disease 12 (16.4)
   Stroke 2 (2.7)
   Sleep disturbance 1 (1.4)
Comorbid disease categories, n (%)  
   Ocular* 31 (42.5)
   Other 55 (75.3)
Comorbid diseases  
   N 63
   Mean (SD) 3.1 (1.5)
   Median (range) 3 (1 -- 7)
  1. * Includes diabetic retinopathy, glaucoma, congenital degeneration of the retina, ocular tumour, cataract, and low vision due to other reasons.
  2. Among subjects with comorbid conditions.
  3. SD = standard deviation.